ODDB.org: Open Drug Database

Mepha Pharma AG - Efavirenz-Emtricitabin-Tenofovir-Mepha 600 mg, 200 mg, 245 mg, Filmtabletten

Swissmedic Registration	66217	Sequence	01
Product name	Efavirenz-Emtricitabin-Tenofovir-Mepha 600 mg, 200 mg	Description	245 mg, Filmtabletten
ATC-Classification	J05AR06	ATC-Description	Emtricitabine, Tenofovir Disoproxil and Efavirenz
Introduction of Sequence	18.07.2017

Composition

efavirenzum 600 mg, emtricitabinum 200 mg, tenofovirum disoproxilum 245 mg ut tenofoviri disoproxili phosphas, cellulosum microcristallinum, carmellosum natricum conexum, mannitolum, hydroxypropylcellulosum, poloxamerum 407, crospovidonum, hypromellosum, hydroxypropylcellulosum substitutum humile, oleum vegetabile hydrogenatum, natrii stearylis fumaras, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, E 171, E 120, pro compresso obducto corresp. natrium 7.23 mg.

Packungsbestandteile

Galenic Form

Active Agent	Dose
Efavirenz	600 mg
Emtricitabine	200 mg
Tenofovir Disoproxil	245 mg

BAG: Active Agent	Dose
Efavirenz	600 mg
Emtricitabine	200 mg
Tenofovir Disoproxil	245 mg

Inactive agents	Dose	additional_information



		color.
		color.


Hypromellosum
Macrogol	3350
Mannitol


Poloxamer	407
		Überzug

Talcum

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
001	30	526.02	588.50	A	SL	No
002	3 x 30	PR	PR	A		Yes

2025	©ywesee GmbH